Search Results - "Heller, P.G."

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia by Antony-Debré, I, Duployez, N, Bucci, M, Geffroy, S, Micol, J-B, Renneville, A, Boissel, N, Dhédin, N, Réa, D, Nelken, B, Berthon, C, Leblanc, T, Mozziconacci, M-J, Favier, R, Heller, P G, Abdel-Wahab, O, Raslova, H, Latger-Cannard, V, Preudhomme, C

Get full text

Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets by Glembotsky, A. C., Bluteau, D., Espasandin, Y. R., Goette, N. P., Marta, R. F., Marin Oyarzun, C. P., Korin, L., Lev, P. R., Laguens, R. P., Molinas, F. C., Raslova, H., Heller, P. G.

“…Summary Background Familial platelet disorder with a predisposition to acute myelogenous leukemia (FPD/AML) is an inherited platelet disorder caused by a…”
Get full text

Anagrelide platelet‐lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms by Espasandin, Y. R., Glembotsky, A. C., Grodzielski, M., Lev, P. R., Goette, N. P., Molinas, F. C., Marta, R. F., Heller, P. G.

“…Summary Background and Objectives Anagrelide represents a treatment option for essential thrombocythemia patients. It lowers platelet counts through inhibition…”
Get full text

International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country by GLEMBOTSKY, A. C., MARTA, R. F., PECCI, A., DE ROCCO, D., GNAN, C., ESPASANDIN, Y. R., GOETTE, N. P., NEGRO, F., NORIS, P., SAVOIA, A., BALDUINI, C. L., MOLINAS, F. C., HELLER, P. G.

“…Background:  Inherited thrombocytopenias (ITs) are heterogeneous genetic disorders that frequently represent a diagnostic challenge. The requirement of highly…”
Get full text

Monocyte IL-2Rα expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms by Goette, N.P., Lev, P.R., Heller, P.G., Kornblihtt, L.I., Korin, L., Molinas, F.C., Marta, R.F.

“…The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (ET). Monocyte activation has been associated…”
Get full text

Diverse Mpl expression pattern among pedigrees with inherited thrombocytopenia: potential diagnostic and therapeutic implications by HELLER, P. G., GLEMBOTSKY, A. C., GOETTE, N. P., MARTA, R. F., LEV, P. R., MOLINAS, F. C.

Get full text

Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations by Kornblihtt, L.I, Heller, P.G, Correa, G, Castañón, M, Genoud, V, Vassallu, P, Sarano, J, Kordich, L, Molinas, F.C

Get full text